Bevacizumab/carboplatin/vinorelbineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1917卷 / 1期

关键词：

D O I：

10.1007/s40278-022-19999-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：128 / 128

相关论文

共 50 条

[31] Bevacizumab/carboplatin/gemcitabineBone marrow dysfunction: case report
Reactions Weekly, 2019, 1751 (1) : 71 - 71
[32] Bevacizumab/carboplatin/paclitaxelLack of efficacy
Reactions Weekly, 2024, 1990 (1) : 34 - 34
[33] VinorelbineLack of efficacy
Reactions Weekly, 2024, 2011 (1) : 420 - 420
[34] Carboplatin/gemcitabineLack of efficacy: case report
Reactions Weekly, 2023, 1953 (1) : 127 - 127
[35] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 142 - 142
[36] Carboplatin/etoposideLack of efficacy: case report
Reactions Weekly, 2022, 1930 (1) : 157 - 157
[37] Carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1954 (1) : 143 - 143
[38] Carboplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1932 (1) : 168 - 168
[39] Carboplatin/gemcitabineLack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 113 - 113
[40] Carboplatin/gemcitabineLack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 105 - 105

← 1 2 3 4 5 →